A detailed history of Systematic Alpha Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Systematic Alpha Investments, LLC holds 296,292 shares of BMY stock, worth $17.1 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
296,292
Previous 296,292 -0.0%
Holding current value
$17.1 Million
Previous $12.3 Million 24.61%
% of portfolio
0.56%
Previous 0.45%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $4.49 Million - $4.89 Million
72,492 Added 32.39%
296,292 $20 Million
Q1 2021

Apr 16, 2021

BUY
$59.34 - $66.74 $3.06 Million - $3.44 Million
51,500 Added 29.89%
223,800 $14.1 Million
Q4 2020

Apr 16, 2021

BUY
$57.74 - $65.43 $9.95 Million - $11.3 Million
172,300 New
172,300 $10.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Systematic Alpha Investments, LLC Portfolio

Follow Systematic Alpha Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Alpha Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Alpha Investments, LLC with notifications on news.